1.5 Million and Counting: What Cambridge Researchers Found Missing From the GLP-1 Diet
This autumn, a figure from Cambridge has been doing the rounds in nutrition circles: an estimated 1.5 million people in the UK are now using GLP-1 medications, and roughly 95% of them are accessing these drugs privately, often without any structured nutritional support. The finding comes from a systematic review by researchers at the University of Cambridge's MRC Epidemiology Unit and UCL's Centre for Obesity Research, published in Obesity Reviews in January 2026.
The headline isn't that the medications work. It's what can happen while they do. Appetite suppression this effective can cut calorie intake by 16 to 39 percent — and lean body mass, including muscle, can account for up to 40 percent of the weight lost. "If nutritional care is not integrated alongside treatment," said lead author Dr Marie Spreckley, "there's a risk of replacing one set of health problems with another." Her co-author, Dr Adrian Brown of UCL, put it plainly: reduced food intake "could compromise dietary quality, meaning people may not get enough protein, fibre, vitamins, and minerals essential for maintaining overall health."
A parallel analysis covered by Harvard Health this spring, drawing on data from nearly half a million adults, found vitamin D deficiency in 13.6 percent of patients after a year of treatment, with measurable drops in iron and B vitamins too. The researchers' advice was not to eat less carefully. It was to eat more deliberately — fewer calories, but every one of them doing more work.
It is a small but telling signal of a larger shift. For a decade, the instinct when appetite or energy faltered was to reach for a capsule. Increasingly, the clinical conversation is circling back to something simpler: when you are eating less, what you do eat has to carry more. That is not a new idea. It is, in fact, the oldest idea in nutrition science — and it happens to be one that a spoonful of good olive oil has been quietly demonstrating for years.
Why fat quality, not just quantity, matters
The British Heart Foundation is measured on the subject, as it should be: a teaspoon of olive oil is mostly monounsaturated fat, the kind linked with healthier cholesterol balance when it replaces saturated fats like butter. But olive oil carries something butter never will — polyphenols, the antioxidant and anti-inflammatory plant compounds that the European Food Safety Authority has formally recognised as protecting blood lipids from oxidative stress, under the olive oil health claim set out in EU Regulation 432/2012. It is a modest, well-earned claim — and a useful reminder that not all fats are created equal when every calorie needs to count.
This is the quiet logic behind a daily ritual, rather than a daily supplement. A multivitamin can patch a gap. It cannot replicate what a living, harvest-dated oil delivers alongside its fat: a dense, variable spectrum of polyphenols, carried in a form the body has spent millennia learning to use.
Ritual over intervention
At Oliiv, we have always framed olive oil less as a cooking ingredient and more as a daily practice — one spoonful, taken consistently, rather than a single dramatic claim. That framing matters more, not less, in a year when so many people are eating less overall. A ritual is forgiving of smaller portions because it asks for consistency, not volume. One tablespoon of a genuinely fresh, polyphenol-rich oil contributes meaningfully to the day's nutrient density, in a way a hastily skipped meal cannot undo.
Freshness is where that density actually comes from. Polyphenol content falls steadily from the moment an olive is picked, which is why we press within hours of harvest and publish the harvest date on every batch, rather than a vague best-before year. Oils made from single-estate, regeneratively farmed groves — where the trees are under less chemical stress — consistently test higher in these compounds than mass-blended oils of uncertain origin. Provenance, in other words, is not a flourish. It is the difference between a fat that simply tastes good and one that is doing something.
A simple ritual, scientifically grounded
None of this is a case against medical treatment, and it isn't medical advice — nutritional needs on GLP-1 therapies are individual, and the Cambridge team is right that they deserve proper clinical support, not a blog post. But the broader pattern they describe, of appetite outpacing nutrient intake, is one more people are living with than the headlines suggest. In that context, a fresh-pressed, early-harvest olive oil earns its place not as a trend, but as a dependable, research-backed source of the healthy fats and polyphenols a smaller plate still needs.
Begin the day with one simple ritual: a spoonful of fresh-pressed olive oil, vibrant and peppery, poured over something real. It will not replace a balanced diet, a doctor's guidance, or a varied plate. But it is one dependable thing to get right, every day, regardless of how much else changes on the plate around it.
Sources: University of Cambridge, "Lack of support for people on weight loss drugs leaves them vulnerable to nutritional deficiencies, say experts" (cam.ac.uk, January 2026), reporting on Spreckley et al., Obesity Reviews (DOI: 10.1111/obr.70079); Harvard Health Publishing, "Study: Taking GLP-1 drugs may increase risk of key nutrient deficiencies" (health.harvard.edu, March 2026); British Heart Foundation, "Is olive oil good for you?" (bhf.org.uk, updated March 2026); European Commission, Regulation (EU) No 432/2012 on permitted health claims for olive oil polyphenols (eur-lex.europa.eu).